Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
Oct 27, 2025
03:06
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
In today’s Pharmaceutical Executive Daily, we cover the FDA approval of Bayer’s Lynkuet for menopausal hot flashes, new research suggesting Ozempic may reduce biological age, and Novartis’ $12 billion merger agreement to acquire Avidity Biosciences.
Pharmaceutical Executive